Childrens Mucinex Multi-Symptom Cold

Description

Children's Mucinex® Multi-Symptom Cold is a liquid formulation designed for the relief of multiple cold symptoms. Each 5 mL dose contains the following active ingredients: Dextromethorphan HBr (5 mg), Guaifenesin (100 mg), and Phenylephrine HCl (2.5 mg). This product is indicated for the alleviation of stuffy nose, cough, chest congestion, and to aid in breaking up mucus. The formulation is flavored with Very Berry and is packaged in a volume of 6.8 FL OZ (201 mL). It is suitable for use in children aged 4 years and older.

Uses and Indications

This drug is indicated for the relief of cough and nasal congestion associated with minor throat and bronchial irritation, which may occur due to the common cold or inhaled irritants. It helps to loosen phlegm (mucus) and thin bronchial secretions, facilitating the clearance of bothersome mucus and making coughs more productive.

Additionally, this drug temporarily relieves the intensity of coughing and the impulse to cough, aiding in the ability of children to sleep. It also alleviates nasal congestion and a stuffy nose associated with colds.

There are no teratogenic or nonteratogenic effects reported for this drug.

Dosage and Administration

Healthcare professionals should advise patients to adhere strictly to the following dosage guidelines. The maximum dosage should not exceed 6 doses within a 24-hour period. It is imperative to measure the medication using only the dosing cup provided with the product, and this cup should not be used for any other products to ensure accurate dosing.

For children aged 6 years to under 12 years, the recommended dose is 10 mL every 4 hours as needed. For children aged 4 years to under 6 years, the appropriate dose is 5 mL every 4 hours as needed. The medication is not recommended for use in children under 4 years of age.

Healthcare professionals should ensure that caregivers understand these instructions to promote safe and effective use of the medication.

Contraindications

Use of this product is contraindicated in children who are currently taking a prescription monoamine oxidase inhibitor (MAOI), which includes certain medications for depression, psychiatric or emotional conditions, or Parkinson's disease. Additionally, this product should not be administered for a period of 2 weeks following the discontinuation of an MAOI. If there is uncertainty regarding the presence of an MAOI in a child's prescription medication, consultation with a healthcare professional is advised prior to use.

Furthermore, it is essential to adhere to the recommended dosage and not exceed the directed amount while using this product.

Warnings and Precautions

The use of this product is contraindicated in children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or have taken one within the past two weeks. MAOIs are commonly prescribed for depression, psychiatric or emotional conditions, and Parkinson's disease. If there is uncertainty regarding the presence of an MAOI in a child's prescription medication, it is imperative to consult a healthcare professional, such as a doctor or pharmacist, prior to administration.

Prior to using this product, it is essential to consult a healthcare provider if the child has any of the following conditions: heart disease, high blood pressure, thyroid disease, diabetes, a cough associated with excessive phlegm (mucus), or a persistent or chronic cough, such as that which occurs with asthma.

When administering this product, it is critical to adhere strictly to the recommended dosage. Exceeding the directed dosage may lead to adverse effects.

Should any of the following occur, it is advised to discontinue use and seek medical advice: if the child experiences nervousness, dizziness, or sleeplessness; if symptoms do not improve within seven days or are accompanied by fever; or if a cough persists for more than seven days, recurs, or is associated with fever, rash, or a persistent headache. These symptoms may indicate a more serious underlying condition.

This product must be kept out of reach of children. In the event of an overdose, immediate medical assistance should be sought, or contact with a Poison Control Center should be established without delay.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this medication. Serious adverse reactions may occur, particularly in children who are concurrently taking a prescription monoamine oxidase inhibitor (MAOI) or have taken one within the past two weeks. The use of this medication in such cases is contraindicated.

Before administering this medication to a child, it is advisable to consult a healthcare professional if the child has a history of heart disease, high blood pressure, thyroid disease, diabetes, or a cough that is accompanied by excessive phlegm. Additionally, children with persistent or chronic coughs, such as those associated with asthma, should be evaluated by a doctor prior to use.

Patients should discontinue use and seek medical advice if the child experiences nervousness, dizziness, or sleeplessness. Furthermore, if symptoms do not improve within seven days, or if they are accompanied by fever, it is important to consult a healthcare provider. A cough that persists for more than seven days, recurs, or occurs with fever, rash, or a persistent headache may indicate a serious underlying condition and requires immediate medical attention.

Drug Interactions

The concomitant use of this product with monoamine oxidase inhibitors (MAOIs) is contraindicated in pediatric patients. MAOIs are typically prescribed for the treatment of depression, certain psychiatric conditions, or Parkinson's disease. Administration of this product should be avoided in children who are currently taking an MAOI or have discontinued an MAOI within the past two weeks.

Healthcare professionals are advised to confirm whether a child's prescription includes an MAOI prior to the administration of this product. If there is any uncertainty regarding the presence of an MAOI in the child's medication regimen, consultation with a physician or pharmacist is recommended to ensure patient safety.

Packaging & NDC

Below are the non-prescription pack sizes of Childrens Mucinex Multi-Symptom Cold (dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 4 years of age should not use this medication. For children aged 4 years to under 6 years, the recommended dosage is 5 mL every 4 hours. For those aged 6 years to under 12 years, the dosage increases to 10 mL every 4 hours.

Caution is advised when considering this medication for pediatric patients who are taking a prescription monoamine oxidase inhibitor (MAOI) or have taken one within the past 2 weeks. Prior to use, it is important to consult a healthcare professional if the child has a history of heart disease, high blood pressure, thyroid disease, diabetes, or a cough associated with excessive phlegm or a persistent cough, such as that seen in asthma.

Parents or caregivers should discontinue use and seek medical advice if the child experiences nervousness, dizziness, or sleeplessness. Additionally, if symptoms do not improve within 7 days, or if they are accompanied by fever, or if a cough persists for more than 7 days, recurs, or occurs with fever, rash, or a persistent headache, these may indicate a serious illness requiring further evaluation.

Geriatric Use

Elderly patients may not have specific information regarding the use of Children's Mucinex® Multi-Symptom Cold, as the drug insert does not provide data on geriatric use. Healthcare providers should exercise caution when considering this medication for geriatric patients, particularly in the absence of established safety and efficacy profiles in this population.

It is advisable to monitor elderly patients closely for any adverse effects or unusual responses to the medication, given the potential for altered pharmacokinetics and increased sensitivity to medications in this age group. Additionally, healthcare providers should consider individual patient factors, including comorbidities and concurrent medications, when determining the appropriateness of this treatment for geriatric patients.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider prior to use, as there may be potential risks to the fetus. The use of this product should be carefully considered in light of these risks. No specific dosage modifications are provided for individuals who are pregnant. It is strongly advised that women of childbearing potential discuss the use of this product with their healthcare provider to ensure informed decision-making regarding its use during pregnancy.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of the drug in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with the overdose.

Healthcare professionals should be vigilant for symptoms that may arise from an overdose, although specific symptoms are not detailed in the provided information. The management of an overdose typically involves supportive care and symptomatic treatment, tailored to the individual patient's needs.

It is essential for healthcare providers to remain informed about the appropriate protocols for managing overdose situations, ensuring that patients receive timely and effective care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Reports of side effects have been received through voluntary submissions and surveillance programs. Healthcare professionals and patients are encouraged to report any adverse events to the designated contact number provided for this purpose.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event of an overdose, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

It is crucial to inform patients that this medication should not be used in children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within two weeks of stopping such a medication. Patients should be encouraged to consult with a doctor or pharmacist if they are uncertain whether their child's prescription includes an MAOI.

Patients should be instructed to discontinue use and consult a doctor if their child experiences nervousness, dizziness, or sleeplessness. Additionally, they should be advised to seek medical advice if symptoms do not improve within seven days or if they occur alongside a fever. If a cough persists for more than seven days, recurs, or is accompanied by fever, rash, or a persistent headache, patients should also be directed to stop use and contact a healthcare professional, as these may indicate a serious illness.

While using this product, patients must be reminded not to exceed the recommended dosage. It is also important for healthcare providers to recommend that patients consult a doctor before use if the child has any of the following conditions: heart disease, high blood pressure, thyroid disease, diabetes, or a cough that produces excessive phlegm. Furthermore, patients should be advised to seek medical advice if the child has a persistent or chronic cough, such as that associated with asthma.

Storage and Handling

The product is supplied in a configuration that includes a dosing cup. It is essential to store the product at a temperature range of 20-25°C (68-77°F). Refrigeration is not permitted, as it may compromise the integrity of the product.

To ensure safety and quality, the product features a tamper-evident design; therefore, it should not be used if the neckband on the bottle cap is broken or missing. Proper handling and adherence to these storage conditions are crucial for maintaining the product's efficacy.

Additional Clinical Information

The medication is administered orally. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Childrens Mucinex Multi-Symptom Cold, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)